HCSC is the largest customer-owned health insurer in the United States, operating Blue Cross and Blue Shield® Plans in Illinois, Montana, New Mexico, Oklahoma, and Texas Redwood City, CA, March 15, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Health Care […]
2021 Ruling Also Increases Hospital Outpatient Payment for the Associated Ambulatory Payment Classification That Covers the Sonata Treatment Redwood City, CA, March 9, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that The Centers for Medicare and Medicaid Services (CMS) has included […]
Detroit Medical Center’s Danny Benjamin, M.D., FACOG, Chief of Obstetrics and Gynecology at DMC Huron Valley-Sinai Hospital, is the first to provide the uterus-preserving, outpatient treatment option to women in Michigan Redwood City, CA, January 21, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, […]
MedStar Health is the first health system to provide Sonata, an incision-free, uterus-preserving, outpatient treatment option for women in the Maryland and Washington D.C. area Redwood City, CA – December 21, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that MedStar Health, […]
Treatment provides women with a uterus-preserving, incision-free, outpatient option with significant symptom relief and fast recovery Redwood City, October 27, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today continued Sonata expansion in the New York area, including NewYork-Presbyterian/Columbia University Irving Medical Center […]
Gynesonics Announces Publication of Long Term Three-Year Results of the SONATA FDA IDE Pivotal Trial
Outcomes Demonstrate Significant and Sustained Symptom Relief, High Patient Satisfaction, Improved Quality of Life and Low Reintervention Rates Redwood City, CA, October 13, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of its peer reviewed journal article, “Three-Year Results of the […]
Sonata System Offers Innovative Incision-Free Fibroid Treatment Option For Women Suffering from Symptomatic Uterine Fibroids Redwood City, Calif., September 22, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today its Sonata® System will be offered by surgeons at Mount Sinai Health System to […]
Sonata Treatment provides patients with an incision-free, outpatient option with exceptional results and fast recovery Redwood City, Calif. – September 3, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Brigham and Women’s Faulkner Hospital is the first provider in Massachusetts to […]
Clinical Study Demonstrates No Adhesion Formation at Second-Look Hysteroscopy Performed Six Weeks After Transcervical Fibroid Ablation with the Sonata System Redwood City, Calif. – August 20, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of the OPEN clinical trial results, demonstrating […]
Redwood City, CA – August 17, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Nelson Whistance has been named Vice President of U.S. Sales. Mr. Whistance reports directly to the President and CEO, Christopher M. Owens. “Nelson is a […]